Peptidyl ketones as inhibitors of DPIV

Details for Australian Patent Application No. 2002331224 (hide)

Owner Prosidion Limited

Inventors Demuth, Hans-Ulrich; Niestroj, Andre; Heiser, Ulrich; Hoffmann, Torsten

Agent Watermark

Pub. Number AU-B-2002331224

PCT Number PCT/EP02/08929

PCT Pub. Number WO2003/033524

Priority 101 50 203.6 12.10.01 DE

Filing date 9 August 2002

Wipo publication date 28 April 2003

Acceptance publication date 17 January 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

6 February 2003 Complete Application Filed

  Priority application(s): 101 50 203.6 12.10.01 DE

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002331224

2 September 2004 Assignment before Grant

  Probiodrug AG The application has been assigned to Prosidion Limited

17 January 2008 Application Accepted

  Published as AU-B-2002331224

15 May 2008 Standard Patent Sealed

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002331225-USE OF INHIBITORS OF PROLINE ENDOPEPTIDASE TO MODULATE INOSITOL (1,4,5) TRIPHOSPHATE CONCENTRATION DEPENDENT ON INTRACELLULAR SIGNAL CASCADES

2002331223-PHARMACEUTICAL COMPOSITION CONTAINING CASPASE-8 AND/OR CASPASE-9 USEFUL FOR OVERCOMING GLUCOCORTICOIDAND CANCER THERAPY-INDUCED APOPTOSIS RESISTANCE OF TUMOURS